Oxurion NV — Major Shareholding Notification 2024

Apr 25, 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

April 25, 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:

Oxurion received a transparency notification on April 25, 2024, from Atlas Special Opportunities, LLC indicating that as of April 19, 2024, it held 380,755,774 shares of the then outstanding 9,014,821,287 shares, and therefore crossed below the threshold (5%) by virtue of the sale of voting securities. See Annex 1.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

For further information please contact:

Oxurion NV	Backstage Communication
Pascal Ghoson	Jurgen Vluijmans
Chief Executive Officer	Partner
Pascal.ghoson@oxurion.com	jurgen@backstagecom.be

1. Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.

ANNEX 1

________

FSMA	FINANCIAL SERVICES AND MARKETS AUTHORITY	Transparency notification Form TR-1 BE PARTI
1)Status of the notification
	Final
2)Issuer
	Name OXURION
ldentification number 0881-620-924
3)Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4)Notification by
	A person that notifies alone		+
5)Persons subject to the notification requirement
	Name	Address (for legal entities)
	Atlas Special Opportunities LLC	2500 Westchester Avenue, Suite 401, Purchase, NY 10577
	6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Name	Address (for legal entities)
B	Please continue entering the information in part II concerning the persons reterred to in Sections 5 and 6	Part II
7)Date on which the threshold is crossed
		19/04/2024 (DD/MM/YYYY)
8) Threshold that is crossed_(in %)
		ഉ
		If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9)Denominator
	9,014,821,287
	Please enter the denominator before filling in the data
10)Notified details

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Atlas Special Opportunities LLC	886.039.886	380.755.774		4.22%
	TOTAL	380,755,774	0	4.22%	0.00%
	2 Nord with Parasmall of haidean a with 2 = and than Saigh with the nareans who are

+

Start with "groups" of holders. Add subtotals with 2 - , and then finish with the person orlegal entity.
"alone". For groups, start with the ultimate controlling naturalperso

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
	TOTAL			0	0.00%
8	The totals will be updated once you have clicked on
	TOTAL (A & B)			# of voting rights	% of voting rights

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

380,755,774

4.22%

12)In case of proxy voting for only one GM

			DUTANY Y Y
Holder	will cease to hold / will hold again	voting rights as of

13)Additional information

Corpora 2024 (with settenent dete on 9 Anil 19,710,388 share in Courin W. As pressed of which its share in Courin its share holor in share holding decreased by 4,323, 40 shar
denominator = 9.014.821.287).
On 8 care a many of the may 2024 , Alas Special Operamities LC solo 28, 909 907 shares in Courin its sheet of virian in the sheet of 7 16, 20 1 shares (= 7.0 %,
denominator = 9,014,821,287).
On 9 car 2024 (with setlement dele on 1 Acril 2024). Altes Special in 2007 (1 shares in Ocainon N. 25, p.m.). Its sheeholding decreased by 033,000 shares (= 7.7 %,
denominator = 9.014.821.287).
On 11 And 2024 with setterner dole on 15 And 2024, Alas Special Operatives LC sold 14,755,27 shares in Orariot its sheeholing percessed by 56,278, 55 shares = 0.18 %.
denominator = 9,014,821,287).
On 10 4pm 2024 (with setternet date on 18 April 2024). Alas Special Operation N. as a result which its sheetholing decessed of 57,988,800 shares = 5.08%.
denominator = 9,014,821,287).
On 17 And 2024 with setternet date on 19 Antil 2024. Also 17,244.25 stere in Oxurion N. as a real of which its hare boling decreased b 30,755,774 shares = 4.2 %.
denominator = 9.014,821,287).

	Done at New York
On		22/04/2024 (DD/MM/YYYY)
	Name & capacity Patrick Vance, proxyholder

For security reasons, the unsigned form in xlsx format should be
transmitted to trp.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via th Send" button.

In addition, a signed copy in PDE format should also be
transmitted.

Attachments

• EN
• NL